middl
east
respiratori
syndrom
coronaviru
merscov
initi
identifi
saudi
arabia
decemb
laboratoryconfirm
case
camel
known
natur
host
merscov
sourc
zoonot
infect
zoonot
transmiss
event
may
mild
unrecogn
may
lead
transmiss
human
thu
lead
mer
outbreak
health
care
facil
sar
epidem
herald
repeat
small
zoonot
outbreak
selflimit
strain
sar
cov
well
adapt
human
emerg
led
global
epidem
affect
approxim
patient
countri
across
five
contin
given
demonstr
capac
novel
coronavirus
emerg
anim
caus
major
outbreak
human
threat
merscov
remain
caus
global
health
concern
vaccin
dromedari
camel
propos
mean
reduc
threat
zoonot
mer
therefor
import
establish
epidemiolog
merscov
transmiss
within
camel
especi
whether
prior
infect
protect
subsequ
reinfect
therefor
carri
longitudin
studi
two
camel
herd
kingdom
saudi
arabia
elucid
merscov
infect
transmiss
nasal
rectal
swab
serum
sampl
collect
dromedari
camel
two
herd
eastern
central
region
saudi
arabia
septemb
may
anim
resampl
whenev
possibl
age
anim
assess
basi
farm
record
record
avail
examin
dentat
swab
sampl
collect
viral
transport
medium
store
herd
group
close
camel
herd
anim
eastern
provinc
camel
hous
one
compound
provid
feed
barn
contact
nomad
camel
herd
occasion
anim
purchas
outsid
exampl
camel
market
may
introduc
herd
previou
studi
camel
herd
publish
herd
group
camel
herd
dromedari
central
provinc
anim
held
one
barn
separ
sever
subgroup
male
pregnant
lactat
anim
differ
anim
group
separ
within
compound
fenc
although
herd
larg
close
anim
purchas
local
market
occasion
introduc
herd
nomad
camel
herd
bedouin
graze
surround
area
especi
fall
winter
anim
sheep
goat
also
sometim
present
area
stray
dog
fox
rodent
bird
dove
crow
also
frequent
seen
proxim
herd
total
nucleic
acid
extract
swab
test
merscov
rna
use
revers
transcript
pcr
rtpcr
rtpcr
assay
target
region
upstream
envelop
protein
gene
upe
use
screen
confirm
screenposit
sampl
done
use
rtpcr
target
open
read
frame
nucleotid
nt
region
genom
spike
gene
n
gene
nt
refer
mersemc
strain
sequenc
rtpcr
amplifi
overlap
pcr
amplicon
sequenc
sanger
sequenc
rtpcrposit
sampl
evid
coronavirus
sought
test
swab
sampl
use
pancoronavirusnest
pcr
target
conserv
rnadepend
rna
polymeras
rdrp
gene
coronavirus
previous
develop
report
merscov
antibodi
test
use
valid
merscov
spike
pseudoparticl
neutral
test
ppnt
previous
describ
herd
camel
includ
calv
sampl
sampl
octob
novemb
januari
februari
anim
swab
serum
collect
except
one
anim
novemb
one
januari
one
februari
merscov
rna
detect
camel
sampl
herd
tabl
camel
sampl
merscov
antibodi
thu
indic
past
infect
herd
dromedari
sampl
includ
calv
year
age
anim
year
age
anim
year
age
anim
undetermin
age
ten
camel
sampl
number
swab
sera
collect
sampl
occas
detail
tabl
result
summar
tabl
nasal
rectal
swab
collect
except
indic
tabl
mersrna
detect
nasal
swab
three
dromedari
novemb
tabl
thu
suggest
herd
infect
merscov
correspond
rectal
swab
rtpcr
neg
viral
load
three
nasal
swab
specimen
copi
per
ml
specimen
copi
per
ml
specimen
copi
per
ml
specimen
tabl
three
anim
seroposit
sampl
carri
novemb
demonstr
fourfold
increas
antibodi
titer
infect
tabl
nt
region
genom
spike
gene
n
gene
sequenc
three
posit
sampl
genbank
access
number
three
set
sequenc
found
ident
thu
suggest
singl
viru
introduc
herd
sequenc
close
relat
genet
ident
merscov
strain
genbank
access
previous
report
dromedari
saudi
arabia
figur
addit
nt
region
n
gene
nt
merscov
genom
sequenc
three
virus
found
ident
phylogeni
also
confirm
virus
ident
close
relat
data
shown
pancoronaviru
rtpcr
detect
known
like
unknown
coronavirus
neg
longitudin
studi
two
dromedari
herd
demonstr
high
level
seroposit
herd
result
agreement
find
mani
studi
report
high
seropreval
adult
anim
arabian
peninsula
africa
one
herd
name
herd
evid
activ
merscov
infect
rtpcr
detect
merscov
confirm
infect
three
camel
novemb
viral
molecular
epidemiolog
confirm
three
infect
probabl
aros
introduct
one
viru
herd
three
anim
rtpcr
posit
merscov
novemb
seroposit
previou
serum
sampl
octob
reinfect
spite
prior
moder
titer
high
antibodi
titer
anim
year
age
serum
antibodi
detect
prior
infect
would
result
infect
birth
rather
antibodi
passiv
acquir
dam
given
camel
age
natur
infect
occur
within
past
year
previou
studi
anoth
infect
camel
herd
shown
infect
adult
calv
adult
anim
like
seroposit
calf
like
matern
antibodi
found
infect
presum
neither
prior
natur
infect
passiv
antibodi
would
produc
steril
immun
howev
conclus
evid
antibodi
detect
prior
infect
lack
correl
viral
rna
load
level
neutral
antibodi
camel
slaughter
abattoir
qatar
also
taken
indic
prior
antibodi
may
provid
steril
immun
howev
conclus
evid
presenc
antibodi
infect
avail
contrast
studi
infect
within
camel
herd
whose
dam
calf
pair
studi
report
infect
occur
calv
seroposit
dam
thu
suggest
prior
immun
older
anim
may
prevent
reinfect
anoth
studi
calv
prospect
follow
first
year
life
five
calv
found
infect
within
first
month
life
even
though
evid
passiv
acquir
matern
antibodi
thu
suggest
matern
antibodi
provid
complet
protect
reinfect
evid
reinfect
adult
seroposit
camel
also
report
longitudin
studi
camel
egypt
present
studi
provid
conclus
evid
reinfect
previous
seroposit
camel
occur
observ
import
implic
feasibl
use
vaccin
camel
mean
control
merscov
transmiss
within
camel
herd
aim
reduc
zoonot
transmiss
reinfect
previous
seroposit
anim
may
occur
merscov
infect
camel
mucos
infect
serum
antibodi
might
accur
predictor
effect
mucos
antivir
immun
provid
steril
immun
none
studi
date
includ
test
evid
mucos
iga
immun
oral
nasopharyng
caviti
defici
remain
crucial
gap
understand
protect
reinfect
lack
protect
natur
reinfect
field
thu
rais
question
potenti
durat
protect
confer
merscov
infect
vaccin
previou
experiment
studi
camel
vaccin
vacciniavector
merscov
vaccin
challeng
week
later
dose
tcid
merscov
inocul
intranas
show
decreas
complet
elimin
detect
viru
rna
infecti
viru
howev
test
experiment
challeng
may
nonphysiolog
dose
viru
short
postvaccin
interv
condit
may
reflect
situat
field
experiment
infect
alpaca
found
protect
merscov
reinfect
studi
involv
challeng
occur
short
interv
previou
infect
contrast
data
experiment
challeng
vaccin
anim
studi
merit
infect
dose
lead
infect
physiolog
relev
field
condit
challeng
probabl
occur
mani
month
year
initi
infect
viral
load
nasal
swab
three
rtpcrposit
specimen
low
rang
copi
per
ml
contrast
viral
load
camel
previous
report
studi
transmiss
within
camel
herd
rang
copi
per
ml
clear
whether
low
viral
load
observ
reinfect
anim
herd
would
suffici
result
onward
transmiss
anim
addit
three
rtpcrposit
camel
serolog
data
confirm
evid
infect
three
camel
earli
septemberoctob
confirm
infect
activ
novemb
period
whether
infect
also
result
viru
introduct
confirm
possibl
like
case
singl
introduct
merscov
would
probabl
led
viru
circul
herd
septemb
least
novemb
period
month
previou
studi
herd
demonstr
viru
circul
least
month
novemberdecemb
data
studi
show
camel
herd
rtpcr
posit
demonstr
fourfold
increas
antibodi
titer
although
two
camel
show
nonsignific
twofold
increas
titer
thu
exclud
infect
sampl
anim
whose
antibodi
titer
observ
rise
fourfold
usual
criterion
signific
antibodi
respons
observ
anim
herd
sampl
detect
six
infect
camel
like
underestim
extent
transmiss
within
herd
age
data
avail
sampl
camel
herd
among
anim
known
age
camel
evid
merscov
infect
either
rtpcr
serolog
test
age
year
younger
wherea
merscovneg
anim
similar
age
fisher
test
p
result
suggest
younger
camel
like
acquir
infect
within
infect
herd
previous
report
limit
present
studi
viral
load
data
avail
one
point
time
time
cours
infect
interv
specimen
month
furthermor
specimen
collect
everi
month
anim
follow
inform
mucos
antibodi
titer
would
use
known
antibodi
function
exampl
neutral
virus
difficult
accur
assay
presenc
mani
nonantibodymedi
mechan
viru
neutral
saliva
anoth
limit
studi
neutral
test
done
mer
emc
strain
rather
contemporari
merscov
strain
howev
other
shown
genet
divers
merscov
antigen
homogen
crossneutr
test
carri
convent
microneutr
pseudotyp
neutral
test
thu
viru
antigen
variat
unlik
confound
serolog
test
lead
antigen
escap
prior
antibodi
immun
conclus
demonstr
reinfect
camel
previous
seroposit
high
serum
antibodi
titer
may
possibl
reinfect
associ
lower
viral
load
may
less
transmiss
anim
hypothesi
remain
confirm
welldesign
field
studi
vaccin
anim
follow
period
longer
year
would
requir
assess
effect
vaccin
decreas
viru
transmiss
camel
longitudin
studi
dromedari
herd
report
provid
use
data
design
systemat
studi
